Publication: Selective calcification of rat brain lesions caused by systemic administration of kainic acid
Authors
Gayoso, M.J. ; Al-Majdalawi, A. ; Garrosa, M. ; Calvo, B. ; Díaz-Flores, Lucio
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Dystrophic calcification of previously
damaged areas of nervous tissue occurs in a wide range
of human diseases. The relationship between astroglial
and microglial reactions and deposits of calcium salts
was studied for up to five months in rats with a brain
lesion produced by systemic administration of kainate.
The morphology and atomic composition of the calcium
salt deposits was also studied. Two types of lesions,
sclerotic and liquefactive, were observed. In sclerotic
lesions hyperplasia and hypertrophy of astrocytes
partially substituted for the lost neurons, reaching a
maximum in about twenty-five days after treatment. In
liquefactive lesions, the astrocytic reaction occurred only
around the liquefactive area. Microglial reaction was
similar in both types of lesion and reached its highest
expression in about twenty-five days. Calcium deposits
were observed in the sclerotic but not in the liquefactive
lesions. Clearly distinguishable granules of calcium salts
were observed in sclerotic lesions under scanning
electron microscopy after only five days post-injection.
The size of calcified granules increased with time
reaching 40 µm or more in diameter at five months. The
atomic composition of these deposits, studied by X-ray
microanalysis, showed a time-dependent increase in
calcium concentration. While there was no clear
relationship between astroglial and microglial reactions
and calcium salt deposits, the systemic injection of
kainate produced progressively larger and more
concentrated calcium deposits in sclerotic, but not in
liquefactive lesions.
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Sin licencia Creative Commons.